Adelaide Research & Scholarship: Search

Search

Search:
for

Current filters:

Start a new search

Add filters:

Results/Page | Sort items by In order Authors/record

Results 31-40 of 49 (Search time: 0.002 seconds).

previous
1
2
3
4
5
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2015	HCFC1 loss-of-function mutations disrupt neuronal and neural progenitor cells of the developing brain.	Jolly, L.; Nguyen, L.; Domingo, D.; Sun, Y.; Barry, S.; Hancarova, M.; Plevova, P.; Vlckova, M.; Havlovicova, M.; Kalscheuer, V.; Graziano, C.; Pippucci, T.; Bonora, E.; Sedlacek, Z.; Gecz, J.
	2015	TRPV1 channels and gastric vagal afferent signalling in lean and high fat diet induced obese mice	Kentish, S.; Frisby, C.; Kritas, S.; Li, H.; Hatzinikolas, G.; O'Donnell, T.; Wittert, G.; Page, A.; Cota, D.
	2015	Contribution of the two genes encoding histone variant H3.3 to viability and fertility in mice	Tang, M.; Jacobs, S.; Mattiske, D.; Soh, Y.; Graham, A.; Tran, A.; Lim, S.; Hudson, D.; Kalitsis, P.; O Bryan, M.; Wong, L.; Mann, J.; Tremethick, D.
	2015	LRGUK-1 is required for basal body and manchette function during spermatogenesis and male fertility	Liu, Y.; DeBoer, K.; de Kretser, D.; O Donnell, L.; O Connor, A.; Merriner, D.; Okuda, H.; Whittle, B.; Jans, D.; Efthymiadis, A.; McLachlan, R.; Ormandy, C.; Goodnow, C.; Jamsai, D.; O Bryan, M.; Yan, W.
	2015	Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice	Lee, E.; Yee, D.; Busfield, S.; McManus, J.; Cummings, N.; Vairo, G.; Wei, A.; Ramshaw, H.; Powell, J.; Lopez, A.; Lewis, I.; McCall, M.; Lock, R.
	2015	Utilising the resources of the International Knockout Mouse Consortium: the Australian experience	Cotton, L.; Meilak, M.; Templeton, T.; Gonzales, J.; Nenci, A.; Cooney, M.; Truman, D.; Rodda, F.; Lynas, A.; Viney, E.; Rosenthal, N.; Bianco, D.; O Bryan, M.; Smyth, I.
	2015	Progesterone receptor modulates ERα action in breast cancer	Mohammed, H.; Russell, I.; Stark, R.; Rueda, O.; Hickey, T.; Tarulli, G.; Serandour, A.; Birrell, S.; Bruna, A.; Saadi, A.; Menon, S.; Hadfield, J.; Pugh, M.; Raj, G.; Brown, G.; D'Santos, C.; Robinson, J.; Silva, G.; Launchbury, R.; Perou, C.; et al.
	2015	BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells	Baker, E.; Taylor, S.; Gupte, A.; Sharp, P.; Walia, M.; Walsh, N.; Zannettino, A.; Chalk, A.; Burns, C.; Walkley, C.
	2015	Systematic screening identifies dual PI3K and mTOR Inhibition as a conserved therapeutic vulnerability in osteosarcoma	Gupte, A.; Baker, E.; Wan, S.; Stewart, E.; Loh, A.; Shelat, A.; Gould, C.; Chalk, A.; Taylor, S.; Lackovic, K.; Karlström, Å.; Mutsaers, A.; Desai, J.; Madhamshettiwar, P.; Zannettino, A.; Burns, C.; Huang, D.; Dyer, M.; Simpson, K.; Walkley, C.
	2015	Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment	Adomako, A.; Calvo, V.; Biran, N.; Osman, K.; Chari, A.; Paton, J.; Paton, A.; Moore, K.; Schewe, D.; Aguirre-Ghiso, J.